Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.74 USD | +0.92% | +4.10% | +4.67% |
Mar. 26 | Bristol Myers: initiatives to advance health equity | CF |
Mar. 25 | Bristol Myers Squibb to Present Data at the American College of Cardiology Annual Scientific Session 2024 | CI |
Financials (USD)
Sales 2024 * | 45.85B | Sales 2025 * | 46.35B | Capitalization | 108B |
---|---|---|---|---|---|
Net income 2024 * | 7.19B | Net income 2025 * | 10.52B | EV / Sales 2024 * | 3.09 x |
Net Debt 2024 * | 33.89B | Net Debt 2025 * | 25.64B | EV / Sales 2025 * | 2.88 x |
P/E ratio 2024 * |
14.2
x | P/E ratio 2025 * |
9.56
x | Employees | 34,100 |
Yield 2024 * |
4.56% | Yield 2025 * |
4.76% | Free-Float | 69.08% |
Latest transcript on Bristol-Myers Squibb Company
1 day | +0.14% | ||
1 week | +2.64% | ||
Current month | +4.93% | ||
1 month | +5.42% | ||
3 months | +3.98% | ||
6 months | -8.02% | ||
Current year | +3.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
Giovanni Caforio
CHM | Chairman | 59 | 99-12-31 |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 227 M€ | +6.90% | - | |
4.99% | 2 M€ | -.--% | ||
4.01% | 18 M€ | +7.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 53.73 | +0.90% | 1 404 397 |
24-03-27 | 53.25 | +1.33% | 13,077,608 |
24-03-26 | 52.55 | +0.57% | 9,951,952 |
24-03-25 | 52.25 | +0.62% | 12,348,068 |
24-03-22 | 51.93 | +0.66% | 11,727,720 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.78% | 108B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.70% | 210B | |
+1.36% | 210B | |
-6.95% | 201B | |
-3.51% | 157B |